Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egon Stenager

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Journal of Neurology|April 28, 2022
Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational studyLars G Hvid, Egon Stenager, Ulrik Dalgas
Expert Review of Neurotherapeutics|November 20, 2018
Preventing suicidal behavior in patients with multiple sclerosis: a scoping reviewAngelina Mellentin, Elsebeth Nylev Stenager, Egon Stenager
International Journal of Adolescent Medicine and Health|August 23, 2012
Sexual problems in multiple sclerosisEgon Stenager, Elsebeth Nylev Stenager, Knud Jensen
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 16, 2022
Physical exercise in multiple sclerosis is not just a symptomatic therapy, it has a disease-modifying effect: CommentaryUlrik Dalgas, Egon Stenager, Lars G Hvid
Archives of Physical Medicine and Rehabilitation|July 4, 2016
Muscle Strength and Poststroke Hemiplegia: A Systematic Review of Muscle Strength Assessment and Muscle Strength ImpairmentOtto H Kristensen, Egon Stenager, Ulrik Dalgas
Ugeskrift for Laeger|November 5, 2015
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis]Henadzi Bazinski, Henrik Boye Jensen, Egon Stenager
Ugeskrift for Laeger|October 29, 2014
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis]Henadzi Basinski, Henrik Boye Jensen, Egon Stenager
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Risk of multiple sclerosis in nurse anaesthetistsEgon Stenager, Henrik Brønnum-Hansen, Nils Koch-Henriksen
Ugeskrift for Laeger|February 26, 2003
[Disability retirement pension for patients with syndrome diagnoses. A registry study on the basis of data from the Social Appeal Board]Elsebeth N Stenager, Morten Aagren Svendsen, Egon Stenager
Brain : a Journal of Neurology|February 13, 2004
Trends in survival and cause of death in Danish patients with multiple sclerosisHenrik Brønnum-Hansen, Nils Koch-Henriksen, Egon Stenager
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Journal of Neurology|April 28, 2022
Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational studyLars G Hvid, Egon Stenager, Ulrik Dalgas
Expert Review of Neurotherapeutics|November 20, 2018
Preventing suicidal behavior in patients with multiple sclerosis: a scoping reviewAngelina Mellentin, Elsebeth Nylev Stenager, Egon Stenager
International Journal of Adolescent Medicine and Health|August 23, 2012
Sexual problems in multiple sclerosisEgon Stenager, Elsebeth Nylev Stenager, Knud Jensen
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 16, 2022
Physical exercise in multiple sclerosis is not just a symptomatic therapy, it has a disease-modifying effect: CommentaryUlrik Dalgas, Egon Stenager, Lars G Hvid
Archives of Physical Medicine and Rehabilitation|July 4, 2016
Muscle Strength and Poststroke Hemiplegia: A Systematic Review of Muscle Strength Assessment and Muscle Strength ImpairmentOtto H Kristensen, Egon Stenager, Ulrik Dalgas
Ugeskrift for Laeger|November 5, 2015
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis]Henadzi Bazinski, Henrik Boye Jensen, Egon Stenager
Ugeskrift for Laeger|October 29, 2014
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis]Henadzi Basinski, Henrik Boye Jensen, Egon Stenager
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Risk of multiple sclerosis in nurse anaesthetistsEgon Stenager, Henrik Brønnum-Hansen, Nils Koch-Henriksen
Ugeskrift for Laeger|February 26, 2003
[Disability retirement pension for patients with syndrome diagnoses. A registry study on the basis of data from the Social Appeal Board]Elsebeth N Stenager, Morten Aagren Svendsen, Egon Stenager
Brain : a Journal of Neurology|February 13, 2004
Trends in survival and cause of death in Danish patients with multiple sclerosisHenrik Brønnum-Hansen, Nils Koch-Henriksen, Egon Stenager
Pageof 14